Last reviewed · How we verify
NCT04995289
Prone Position During ECMO in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Hypoxaemic Patient
trial testing Prone position on ECMO patient in SARS CoV 2 Infection in 23 participants. Completed in 30 January 2021.
30 January 2021
Quick facts
| Lead sponsor | Mohammed VI University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 23 |
| Start date | 1 January 2020 |
| Primary completion | 30 January 2021 |
| Estimated completion | 30 January 2021 |
| Sites | 1 location across Morocco |
Drugs / interventions tested
- Prone position on ECMO patient
Conditions studied
- SARS CoV 2 Infection — all drugs for SARS CoV 2 Infection →
- Hypoxemic Respiratory Failure — all drugs for Hypoxemic Respiratory Failure →
Sponsor
Mohammed VI University Hospital
Who can join
Eligibility, any sex, with SARS CoV 2 Infection or Hypoxemic Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction: The main manifestation of COVID-19 pneumonia is acute respiratory distress syndrome (ARDS), which in some cases can be more severe than intubation, extracorporeal membrane venous oxygenation (VV-ECMO) to ensure hematosis. Despite support from VV-ECMO, some patients may remain hypoxemic. One possible therapeutic procedure for these patients is the application of the prone position. Objective: The main aim of this study was to investigate the modification of the PaO2/FiO2 ratio, the compliance of the respiratory system in VV-ECMO with refractory hypoxemia. The secondary objective was to evaluate the safety and feasibility of the inclined position for ECMO. Methods: the investigators reviewed the electronic records and lists of all 23 COVID-19 patients. were placed for the first time in PP with an average duration of 16 h . patient characteristics, pre-ECMO characteristics, ventilator/ECMO settings, and changes in ventilator/ECMO settings and blood gas analysis before and after PP.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prone position during ECMO in patients with COVID-19 in Morocco: Case series.
Oujidi Y, Bensaid A, Melhoaui I, Jakhjoukh DD, et al · · 2021 · cited 3× · PMID 34484734 · DOI 10.1016/j.amsu.2021.102769
Verify or expand the search:
- PubMed search for NCT04995289
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for SARS CoV 2 Infection
Currently open trials in the same condition.
- NCT07189936 — Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS · Phase 2 · recruiting
- NCT07197164 — Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients · Phase 2 · recruiting
- NCT06950177 — Pancoronavirus Vaccine Study in Healthy Adults · Phase 1 · active not recruiting
- NCT06640387 — CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools · recruiting
- NCT06633835 — Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the United St · Phase 4 · active not recruiting
Other Mohammed VI University Hospital trials
Trials by the same sponsor.
- NCT05646342 — PLR in a Good Helath After 24 Week of Preganancy · unknown
- NCT06326762 — Gap CO2 in Septic Patient to Predict Cardiomyopathy Septic · completed
- NCT05364723 — Place of Glycation in Diabetic Retinopathy · unknown
- NCT06903754 — ISGLT2 in Patients Without DM With Acute MI · completed
- NCT05771857 — Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04995289 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mohammed VI University Hospital
- Last refreshed: 13 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04995289.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing